試す金 - 無料

BioSpectrum Asia - March 2024

Magzter GOLDで無制限に

読む BioSpectrum Asia 9,500以上の雑誌や新聞を1回の定期購読で購読できます

カタログを見る

1ヶ月

$14.99

1年 $149.99

$149.99

$12/month

(OR)

BioSpectrum Asiaのみを購読する

贈り物 BioSpectrum Asia

いつでもキャンセルできます。

(義務なし) ⓘ

定期購読にご満足いただけない場合は、定期購読開始日から 7 日以内に help@magzter.com までメールをお送りいただければ、全額返金いたします。質問は一切ありません。お約束します! (注: 単号購入には適用されません)

デジタルサブスクリプション

即時アクセス ⓘ

今すぐ購読すると、Magzter の Web サイト、iOS、Android、Amazon アプリですぐに読み始めることができます。

安全性を確認済み

支払い ⓘ

Magzter は Authorize.Net の認定販売業者です。詳細はこちら

この号では

ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES
We are celebrating International Women's Day this time around by spotlighting women's roles and challenges in life sciences, spanning leadership, clinical trials participation and pay parity issues. Section I of the story highlights remarkable women leading public sector organisations in life sciences in APAC. Section II discusses the persistent issue of pay parity in the sector, while the final section tackles issues related to women in clinical trials. Let's delve deeper.

Australia establishes new task force to guide use of AI in public health system

New South Wales (NSW) Health in Australia has established a new taskforce to inform and guide the use of artificial intelligence (AI) in the public health system.

1 mins

Ministry of Health in New Zealand inks MoU with of Waikato to build medical school University

The Ministry of Health, government of New Zealand, and the University of Waikato have signed a Memorandum of Understanding (MoU) as a first step towards establishing a new medical school.

1 mins

NITI Aayog releases report for senior care reforms in India

NITI Aayog has released a position paper titled 'Senior Care Reforms in India: Reimagining the Senior Care Paradigm'.

1 mins

Eris Lifesciences expands footprint in sterile injectables with acquisition of 51% stake in Swiss Parenterals

India-based Eris Lifesciences has announced the expansion of its sterile injectables footprint through the acquisition of 51 per cent equity stake in Swiss Parenterals for a consideration of Rs 637.5 crore.

1 mins

Biocon Biologics partners with Sandoz Australia for cancer biosimilars

Indian firm Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon, has announced a five-year partnership with Sandoz AG which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million) and biosimilar Bevacizumab (market value of AUD$45 million) in Australia.

1 mins

Samsung Biologics & LegoChem Biosciences team up for ADC development

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has signed a partnership agreement with LegoChem Biosciences, a Korean biotech company pioneering the research and development of antibody-drug conjugate (ADC) programmes.

1 mins

Taiwan's Anbogen secures $12.5M for advancing precision oncology drug development

Taiwan-based startup Anbogen Therapeutics, a clinical-stage biotechnology company specialising in groundbreaking cancer drug development, has announced the successful completion of its Series A funding round.

1 mins

Japanese startup RevolKa to create highly functional proteins by using AI-driven platform

RevolKa, a venture-backed biotech startup providing a gamechanging protein engineering technology platform, based in Japan, has signed a contract research agreement with Sekisui Chemical.

1 mins

US FDA approves first medication to treat severe frostbite

The US Food and Drug Administration (FDA) has approved Eicos Sciences Inc’s Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

1 mins

ENGENDERING INCLUSIVITY & DIVERSITY IN LIFE SCIENCES

Globally, women constitute 46 per cent of the workforce in the public sector, whereas in the private sector, they represent 33 per cent. The public sector maintains a higher representation of women as employees compared to the private sector as per data from the World Bank.

10+ mins

Championing PAY PARITY

Despite women's significant strides and contributions in the healthcare field, they are paid less than men. Unfortunately, as is the case in most spheres, persistent pay disparities plague the life sciences sector. How big is the gender pay gap in the pharma industry? Are companies and the industry doing enough to address this issue? Let's find out.

6 mins

How pharma is finally researching issues that primarily affect women

Pharma is now concentrating on problems that impact women. Female participation will now directly contribute to cures for diseases that affect them, since more studies specifically targeted at women are planned.

8 mins

Can Shorter Regimens Eliminate Drug-Resistant Tuberculosis?

The World Health Organization (WHO) has taken a significant stride in the battle against Tuberculosis (TB) by introducing shorter drug regimens, aiming to curb a disease that claims countless lives globally. This innovative approach addresses the urgent need for more efficient treatments, especially in regions where TB's toll is highest. With traditional therapies often posing risks to liver health, these shortened regimens offer hope, minimising such concerns while enhancing treatment adherence.

5 mins

Why Singapore is Deep Tech Innovation Frontrunner

Move over Artificial Intelligence Al) and Machine Learning ML), there's a new technology on the block Deep Tech. This latest technology holds immense potential for the life sciences industry, and Singapore is leaving no stone unturned in becoming a deep tech hub. From strategic investments to collaborative initiatives and a supportive regulatory environment, read on to find out about the country's initiatives in becoming a deep tech superpower.

4 mins

Korea designs sweat resistant wearable robot sensor

New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.

1 mins

すべてのストーリーを読む BioSpectrum Asia

BioSpectrum Asia Description:

出版社: MM-Activ-Sci-Tech-Communication

カテゴリ: Business

言語: English

頻度: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.